Our portfolio transformation over the past few years positions us well to capitalize on improving end market conditions and deliver differentiated results in the years to come
The trial aims to assess the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of the combination therapy
TactiFlex, the world’s first catheter with a flexible tip and contact?force sensing, allows doctors to deliver energy precisely and safely.
Takeda said zasocitinib was generally well tolerated, with a safety profile consistent with earlier studies
The combination also outperformed chemotherapy on another important secondary endpoint
Amrutanjan is also rolling out its new campaign, 'Har Dard Mitaye'
Cobenfy generated $43 million in third-quarter sales, up from $35 million in the second quarter
Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
Subscribe To Our Newsletter & Stay Updated
